Insider Trading activities of Myriad Genetics Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myriad Genetics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myriad Genetics Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Myriad Genetics Inc since 2005. The reporting company's ticker symbol is MYGN. The reporting company's CIK number is 899923.
The total value of stock buying since 2005 is $388,130.
The total value of stock sales since 2005 is $224,372,609.
The total value of stock option exercises since 2005 is $82,982,293.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Myriad Genetics Inc insiders (MYGN) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-01-25 Critchfield Gregory C (President Myriad Genetic Labs) Option Ex 18,644 7.03 131,084
2007-12-20 Langer Dennis (Director) Sale 20,000 47.62 952,380
2007-12-20 Langer Dennis (Director) Option Ex 20,000 19.09 381,740
2007-12-20 Critchfield Gregory C (President Myriad Genetic Labs) Option Ex 4,900 7.03 34,451
2007-12-19 Langer Dennis (Director) Sale 10,000 47.52 475,150
2007-12-19 Langer Dennis (Director) Option Ex 10,000 17.23 172,300
2007-12-07 Hockett William A Iii (V. P. of Corp Communications) Sale 2,692 50.71 136,319
2007-12-06 Skolnick Mark H (Chief Scientific Officer) Sale 27,000 50.45 1,362,150
2007-12-04 Laslie W Wayne (Chief Operating Officer, MPI) Sale 1,122 48.30 54,192
2007-11-30 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Option Ex 5,000 5.12 25,625
2007-11-30 Wilson Linda S (Director) Sale 25,000 48.20 1,205,075
2007-11-30 Wilson Linda S (Director) Option Ex 23,900 10.76 257,187
2007-11-21 Marsh Richard M (V.P., General Counsel) Option Ex 1,600 20.56 32,896
2007-11-05 Gilbert Walter Phd (Director) Sale 35,000 52.82 1,847,254
2007-11-05 Gilbert Walter Phd (Director) Option Ex 35,000 18.09 638,881
2007-10-22 Marsh Richard M (V.P., General Counsel) Option Ex 1,600 20.56 32,896
2007-10-15 Evans James S (V.P. Finance) Sale 6,555 54.93 360,079
2007-10-15 Hockett William A Iii (V. P. of Corp Communications) Sale 4,886 55.21 269,129
2007-10-15 Moyes Jay M (Chief Financial Officer) Sale 39,520 54.97 2,177,915
2007-10-15 Moyes Jay M (Chief Financial Officer) Option Ex 39,520 12.54 495,578
2007-10-15 Meldrum Peter D (President & C.E.O.) Sale 20,000 55.30 1,105,920
2007-10-11 Laslie W Wayne (Chief Operating Officer, MPI) Sale 10,000 57.26 572,630
2007-10-11 Laslie W Wayne (Chief Operating Officer, MPI) Option Ex 10,000 19.50 195,000
2007-10-05 Lanchbury Jerry S (Executive V.P. - Research) Sale 10,000 86.70 866,979
2007-10-05 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 10,000 13.45 134,480
2007-09-27 Lanchbury Jerry S (Executive V.P. - Research) Sale 10,036 52.01 521,922
2007-09-27 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 10,036 14.81 148,633
2007-09-26 Marsh Richard M (V.P., General Counsel) Sale 6,323 50.00 316,150
2007-09-26 Marsh Richard M (V.P., General Counsel) Option Ex 6,323 12.54 79,290
2007-09-26 Critchfield Gregory C (President Myriad Genetic Labs) Sale 9,342 50.00 467,100
2007-09-26 Critchfield Gregory C (President Myriad Genetic Labs) Option Ex 9,342 4.78 44,664
2007-09-25 Marsh Richard M (V.P., General Counsel) Sale 6,177 50.00 308,850
2007-09-25 Marsh Richard M (V.P., General Counsel) Option Ex 6,177 12.54 77,459
2007-09-25 Critchfield Gregory C (President Myriad Genetic Labs) Sale 18,658 50.00 932,900
2007-09-25 Critchfield Gregory C (President Myriad Genetic Labs) Option Ex 18,658 4.78 89,203
2007-09-25 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Sale 20,000 50.00 1,000,000
2007-09-25 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Option Ex 20,000 5.12 102,500
2007-09-14 Meldrum Peter D (President & C.E.O.) Sale 11,262 47.07 530,124
2007-09-14 Meldrum Peter D (President & C.E.O.) Option Ex 11,262 9.31 104,871
2007-09-13 Evans James S (V.P. Finance) Sale 3,914 47.20 184,729
2007-09-13 Moyes Jay M (Chief Financial Officer) Sale 59,881 47.28 2,833,441
2007-09-13 Moyes Jay M (Chief Financial Officer) Option Ex 59,881 8.94 526,266
2007-09-12 Moyes Jay M (Chief Financial Officer) Sale 20,397 47.16 962,004
2007-09-12 Moyes Jay M (Chief Financial Officer) Option Ex 20,397 6.46 131,683
2007-09-12 Meldrum Peter D (President & C.E.O.) Sale 10,000 47.22 472,150
2007-09-12 Meldrum Peter D (President & C.E.O.) Option Ex 10,000 9.31 93,120
2007-08-09 Lanchbury Jerry S (Executive V.P. - Research) Sale 10,000 47.01 470,070
2007-08-09 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 10,000 14.81 148,100
2007-08-07 Capone Mark Christopher (Chief Operating Officer, MGL) Sale 4,773 43.03 205,406
2007-08-07 Capone Mark Christopher (Chief Operating Officer, MGL) Option Ex 4,773 15.28 72,931
2007-08-07 Laslie W Wayne (Chief Operating Officer, MPI) Sale 9,000 40.25 362,250
2007-08-07 Laslie W Wayne (Chief Operating Officer, MPI) Option Ex 9,000 19.50 175,500
2007-08-07 Lanchbury Jerry S (Executive V.P. - Research) Sale 15,000 42.10 631,545
2007-08-07 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 15,000 14.81 222,150
2007-08-06 Marsh Richard M (V.P., General Counsel) Sale 579 40.00 23,160
2007-07-16 Marsh Richard M (V.P., General Counsel) Sale 5,581 40.00 223,240
2007-06-18 Marsh Richard M (V.P., General Counsel) Sale 6,000 37.81 226,860
2007-06-15 Moyes Jay M (Chief Financial Officer) Sale 1,500 37.73 56,594
2007-06-07 Skolnick Mark H (Chief Scientific Officer) Option Ex 20,000 13.56 271,240
2007-05-31 Skolnick Mark H (Chief Scientific Officer) Sale 30,000 38.29 1,148,610
2007-05-31 Skolnick Mark H (Chief Scientific Officer) Option Ex 30,000 13.56 406,860
2007-05-23 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Sale 10,000 40.00 400,000
2007-05-23 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Option Ex 10,000 5.12 51,250
2007-05-09 Gilbert Walter Phd (Director) Sale 30,000 38.05 1,141,590
2007-05-09 Gilbert Walter Phd (Director) Option Ex 30,000 10.70 321,090
2007-05-08 Skolnick Mark H (Chief Scientific Officer) Sale 30,000 38.06 1,141,770
2007-05-08 Skolnick Mark H (Chief Scientific Officer) Option Ex 30,000 13.56 406,860
2007-05-04 Meldrum Peter D (President & C.E.O.) Sale 20,000 39.38 787,680
2007-05-03 Hayes Arthur Hull Jr (Director) Sale 15,000 39.71 595,710
2007-05-03 Hayes Arthur Hull Jr (Director) Option Ex 15,000 13.00 195,000
2007-05-03 Hockett William A Iii (V. P. of Corp Communications) Sale 84,151 39.74 3,344,413
2007-05-03 Hockett William A Iii (V. P. of Corp Communications) Option Ex 84,151 17.07 1,436,205
2007-05-02 Meldrum Peter D (President & C.E.O.) Sale 9,400 38.00 357,200
2007-05-01 Lanchbury Jerry S (Executive V.P. - Research) Sale 8,750 37.00 323,750
2007-05-01 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 8,750 12.54 109,724
2007-05-01 Marsh Richard M (V.P., General Counsel) Sale 3,991 37.50 149,662
2007-05-01 Meldrum Peter D (President & C.E.O.) Sale 600 38.00 22,800
2007-04-16 Marsh Richard M (V.P., General Counsel) Sale 5,000 36.08 180,385
2007-03-23 Capone Mark Christopher (Chief Operating Officer, MGL) Option Ex 5,400 14.75 79,650
2007-03-13 Hockett William A Iii (V. P. of Corp Communications) Sale 16,725 33.28 556,541
2007-03-13 Hockett William A Iii (V. P. of Corp Communications) Option Ex 16,725 11.64 194,679
2007-03-12 Skolnick Mark H (Chief Scientific Officer) Sale 5,000 33.81 169,050
2007-03-07 Wilson Linda S (Director) Option Ex 2,500 10.19 25,467
2007-02-06 Evans James S (Vice President Finance) Sale 5,626 37.00 208,162
2007-02-06 Evans James S (Vice President Finance) Option Ex 5,626 5.12 28,833
2007-01-16 Simon S George (V.P. Business Development) Sale 5,000 35.09 175,435
2007-01-16 Simon S George (V.P. Business Development) Option Ex 5,000 12.54 62,699
2007-01-12 Simon S George (V.P. Business Development) Sale 5,000 35.00 175,015
2007-01-12 Simon S George (V.P. Business Development) Option Ex 5,000 11.64 58,200
2007-01-12 Meldrum Peter D (President & C.E.O.) Sale 10,000 35.00 350,000
2007-01-11 Lanchbury Jerry S (Executive V.P. - Research) Sale 5,000 34.00 170,000
2007-01-11 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 5,000 12.54 62,699
2007-01-10 Meldrum Peter D (President & C.E.O.) Sale 10,000 33.00 330,000
2007-01-09 Moyes Jay M (Chief Financial Officer) Sale 8,156 32.50 265,070
2007-01-09 Moyes Jay M (Chief Financial Officer) Option Ex 8,156 13.56 110,611
2007-01-03 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Sale 5,000 32.00 160,000
2007-01-03 Hobden Adrian N (Pres. Myriad Pharmaceuticals) Option Ex 5,000 5.12 25,625
2007-01-03 Hockett William A Iii (V. P. of Corp Communications) Sale 5,000 32.00 160,000
2007-01-03 Hockett William A Iii (V. P. of Corp Communications) Option Ex 5,000 4.78 23,905
2006-12-13 Meldrum Peter D (President & C.E.O.) Sale 20,000 30.90 618,000
2006-11-20 Moyes Jay M (Chief Financial Officer) Sale 4,800 30.00 144,000
2006-11-20 Moyes Jay M (Chief Financial Officer) Option Ex 4,800 13.56 65,097
2006-11-17 Moyes Jay M (Chief Financial Officer) Sale 333 30.00 9,990
2006-11-17 Moyes Jay M (Chief Financial Officer) Option Ex 333 13.56 4,516
2006-11-16 Moyes Jay M (Chief Financial Officer) Sale 3,023 30.00 90,690
2006-11-16 Moyes Jay M (Chief Financial Officer) Option Ex 3,023 13.56 40,997
2006-11-15 Lanchbury Jerry S (Executive V.P. - Research) Sale 4,176 29.00 121,104
2006-11-15 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 4,176 12.54 52,367
2006-11-10 Gilbert Walter Phd (Director) Sale 26,297 26.93 708,151
2006-11-09 Gilbert Walter Phd (Director) Sale 9,643 27.14 261,672
2006-11-07 Lanchbury Jerry S (Executive V.P. - Research) Sale 824 29.00 23,896
2006-11-07 Lanchbury Jerry S (Executive V.P. - Research) Option Ex 824 12.54 10,332
2006-10-19 Hockett William A Iii (V. P. of Corp Communications) Sale 8,588 28.00 240,464
2006-10-19 Hockett William A Iii (V. P. of Corp Communications) Option Ex 8,588 5.01 43,025
2006-10-18 Moyes Jay M (Chief Financial Officer) Sale 5,000 27.08 135,395
2006-08-30 Hayes Arthur Hull Jr (Director) Sale 15,000 25.13 376,935
2006-08-30 Hayes Arthur Hull Jr (Director) Option Ex 15,000 14.12 211,875
2006-06-13 Moyes Jay M (Chief Financial Officer) Option Ex 15,444 12.38 191,119
2006-06-07 Skolnick Mark H (Chief Scientific Officer) Sale 27,000 24.93 673,083
2006-06-07 Skolnick Mark H (Chief Scientific Officer) Option Ex 27,000 12.38 334,125
2006-05-08 Skolnick Mark H (Chief Scientific Officer) Sale 21,436 28.00 600,208
2006-05-08 Skolnick Mark H (Chief Scientific Officer) Option Ex 21,436 12.38 265,270
2006-05-05 Simon S George (V.P. Business Development) Sale 10,000 28.02 280,160
2006-05-05 Simon S George (V.P. Business Development) Option Ex 10,000 10.74 107,400
2006-05-04 Meldrum Peter D (President & C.E.O.) Sale 8,628 28.00 241,584
2006-05-04 Meldrum Peter D (President & C.E.O.) Option Ex 8,628 13.56 117,012
2006-04-17 Critchfield Gregory C (President Myriad Genetic Labs) Sale 35,556 24.55 872,935
2006-04-17 Critchfield Gregory C (President Myriad Genetic Labs) Option Ex 35,556 7.03 249,994
2006-03-23 Evans James S (V.P. Finance) Option Ex 1,500 5.12 7,687
2006-03-23 Meldrum Peter D (President & C.E.O.) Option Ex 9,230 11.64 107,437
2006-03-13 Marsh Richard M (V.P., General Counsel) Sale 10,000 27.55 275,520
2006-03-13 Marsh Richard M (V.P., General Counsel) Option Ex 10,000 12.54 125,399
2006-03-10 Skolnick Mark H (Chief Scientific Officer) Option Ex 16,564 12.38 204,979
2006-03-09 Gilbert Walter Phd (Director) Sale 6,300 26.00 163,800
2006-03-09 Gilbert Walter Phd (Director) Option Ex 6,300 13.00 81,900
2006-03-08 Hayes Arthur Hull Jr (Director) Sale 25,000 25.74 643,575
2006-03-08 Hayes Arthur Hull Jr (Director) Option Ex 15,000 5.69 85,305
2006-03-08 Gilbert Walter Phd (Director) Sale 36,600 25.85 946,219
2006-03-08 Gilbert Walter Phd (Director) Option Ex 36,600 10.19 372,844
2006-03-07 Gilbert Walter Phd (Director) Sale 12,100 25.97 314,249
2006-03-07 Gilbert Walter Phd (Director) Option Ex 12,100 14.12 170,912
2006-02-27 Moyes Jay M (Chief Financial Officer) Sale 2,900 25.21 73,100
2006-02-27 Moyes Jay M (Chief Financial Officer) Option Ex 2,900 12.38 35,887
2006-02-13 Meldrum Peter D (President & C.E.O.) Sale 10,000 25.00 250,000
2006-02-10 Hockett William A Iii (V. P. of Corp Communications) Sale 3,588 25.00 89,700
2006-02-10 Hockett William A Iii (V. P. of Corp Communications) Option Ex 3,588 5.12 18,388
2006-02-10 Simon S George (V.P. Business Development) Sale 5,000 25.00 125,000
2006-02-10 Simon S George (V.P. Business Development) Option Ex 5,000 10.74 53,700
2006-02-10 Moyes Jay M (Chief Financial Officer) Sale 12,544 25.03 314,013
2006-02-10 Moyes Jay M (Chief Financial Officer) Option Ex 12,544 12.38 155,232
2005-12-21 Moyes Jay M (Chief Financial Officer) Sale 2,448 19.98 48,911
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of MYGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myriad Genetics Inc (symbol MYGN, CIK number 899923) see the Securities and Exchange Commission (SEC) website.